ArticleImmuno-oncology technology2024

Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma.

D König et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.